References
- American Diabetes Association. Standards of medical care in diabetes – 2016. Diabetes Care 2016;39(Suppl 1):S39–46
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–59
- Nathan D, Buse J, Davidson J, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193–203
- Phillips L, Branch T Jr, Cook C, et al. Clinical Inertia. Ann Intern Med 2001;135:825–34
- Watson L, Das R, Farquhar R, et al. Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database. Curr Med Res Opin 2016; Mar 23: 1-11. [Epub ahead of print] DOI:10.1185/03007995.2016.1157462
- Shah B, Hux J, Laupacis A, et al. Clinical inertia in response to inadequate glycemic control. Diabetes Care 2005;28:600–6
- Paul S, Klein K, Thorsted B, et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol 2015;14:100–9